J. Ross

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.

J. Stec, M. Ayers, K. Hess, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.

J. Stec, M. Ayers, K. Hess, 2005, Endocrine-related cancer.

Comparison of mitotic cyclins and cyclin‐dependent kinase expression in keratoacanthoma and squamous cell carcinoma

J. Ross, J. Carlson, T. Tran, 1999, Journal of cutaneous pathology.

Detecting recurrent bladder cancer: new methods and biomarkers

M. Cohen, J. Ross, J. Ross, 2001, Expert review of molecular diagnostics.

Inhibiting MEK in MAPK pathway-activated myeloma

B. Barlogie, G. Morgan, V. Miller, 2015, Leukemia.

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.

James X. Sun, R. Yelensky, D. Lipson, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Erich A. Peterson, Caleb K. Stein, O. Stephens, 2017, Blood Cancer Journal.